Source: Citybizlist

IRISYS: Recro Acquires IRISYS

EXTON, Pa., Aug. 13, 2021 (GLOBE NEWSWIRE) - Recro Pharma, Inc. (NASDAQ: REPH), a contract development and manufacturing organization (CDMO)... Read MoreThe post Recro Acquires IRISYS appeared first on citybiz.

Read full article »

IRISYS's Competitors | IRISYS's News | IRISYS's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

Chairman & CEO

Gerald J. Yakatan

CEO Approval Rating

86/100

IRISYS is a California-based CDMO that provides services such as clinical development, product formulation and analytical support for the pharmaceutical industry.